Form D · Biotechnology
Akouos, Inc.
Boston, MA · CIK 0001722271
Offering snapshot reported Mar 3, 2020 · SEC filing
- Reported sold
- $105M Offering amount: $105M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2020 | Initial | $105,065,001 | No comparison | 33 | SEC filing |
| Aug 1, 2018 | Initial | $25,050,000 | No comparison | 10 | SEC filing |
| Nov 13, 2017 | Initial | $7,584,933 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-361803
Source: Form D, filed Mar 3, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aninda Katragadda | Executive |
| Ed Mathers | Director |
| Kush Parmar | Director |
| Heather Preston | Director |
| Vicki Sato | Director |
| Karoline Shair | Executive |
| Emmanuel Simons | Director, Executive |
| Chris Smith | Director |
| Arthur Tzianabos | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
645 Summer Street Suite 200
Boston, MA, 02210
Boston, MA, 02210